Strs Ohio Purchases Shares of 44,500 Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Strs Ohio acquired 44,500 shares of Sabra Healthcare REIT, valued at approximately $777,000, during the first quarter, further supporting institutional ownership in the company, which now stands at 99.40%.
• Wall Street analysts have raised their price targets for Sabra Healthcare REIT, with recent estimates ranging from $20.00 to $22.00, indicating positive growth expectations for the stock.
• Sabra Healthcare REIT declared a quarterly dividend of $0.30 per share, reflecting a 6.4% yield and marking a dividend payout ratio of 157.89%.

Strs Ohio bought a new stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 44,500 shares of the real estate investment trust's stock, valued at approximately $777,000.

Other institutional investors have also modified their holdings of the company. Bank of New York Mellon Corp raised its stake in Sabra Healthcare REIT by 1.8% during the first quarter. Bank of New York Mellon Corp now owns 4,114,215 shares of the real estate investment trust's stock worth $71,875,000 after acquiring an additional 74,564 shares during the period. Nuveen LLC acquired a new stake in Sabra Healthcare REIT during the first quarter worth about $61,791,000. Wellington Management Group LLP raised its stake in Sabra Healthcare REIT by 33.7% during the fourth quarter. Wellington Management Group LLP now owns 3,205,042 shares of the real estate investment trust's stock worth $55,511,000 after acquiring an additional 808,207 shares during the period. Advisors Capital Management LLC raised its stake in Sabra Healthcare REIT by 20.5% during the first quarter. Advisors Capital Management LLC now owns 2,232,609 shares of the real estate investment trust's stock worth $39,004,000 after acquiring an additional 380,505 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Sabra Healthcare REIT by 16.8% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,687,977 shares of the real estate investment trust's stock worth $29,489,000 after acquiring an additional 243,274 shares during the period. Institutional investors and hedge funds own 99.40% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on SBRA shares. Truist Financial increased their price objective on shares of Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a "hold" rating in a research note on Tuesday, September 2nd. Wells Fargo & Company upped their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 27th. BMO Capital Markets upped their target price on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a "market perform" rating in a research report on Monday, August 25th. Scotiabank upped their target price on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a research report on Monday, June 23rd. Finally, JMP Securities upped their target price on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research report on Wednesday, August 6th. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $20.83.

Sabra Healthcare REIT Stock Performance

NASDAQ SBRA traded up $0.07 during midday trading on Tuesday, hitting $18.56. The company had a trading volume of 57,990 shares, compared to its average volume of 2,416,550. The firm has a fifty day simple moving average of $18.72 and a two-hundred day simple moving average of $18.07. The stock has a market cap of $4.45 billion, a price-to-earnings ratio of 24.45, a P/E/G ratio of 1.49 and a beta of 0.88. Sabra Healthcare REIT, Inc. has a fifty-two week low of $15.60 and a fifty-two week high of $20.03. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The firm had revenue of $189.15 million during the quarter, compared to the consensus estimate of $185.64 million. During the same period last year, the firm posted $0.36 EPS. The firm's quarterly revenue was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Equities analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Friday, August 15th were issued a dividend of $0.30 per share. The ex-dividend date was Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 6.5%. Sabra Healthcare REIT's payout ratio is currently 157.89%.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.